In patients with COVID-19 and confirmed PE, very high CRP and IL-6 levels, together with extensive parenchymal involvement, identify a subgroup with a markedly increased risk of invasive mechanical ventilation and death, even when D-dimer and thrombus location are not strikingly different. The gene discussed is IL6; the disease is COVID-19.